NCT06637813View on ClinicalTrials.gov

Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine

Not yet recruitingOBSERVATIONAL

Enrollment

1,220

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2034

Conditions

HIV -1 Infection

Interventions

OTHER

Blood sampling for evaluation of biomarkers

Non-routine diagnostic test evaluations

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06637813 - Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine | Biotech Hunter | Biotech Hunter